Story
Apnimed Stock Surges on Bullish Initiations from BofA, Cantor Fitzgerald

Apnimed (APMD) shares surged more than 11% in morning trading after two prominent Wall Street firms initiated coverage with bullish ratings, citing a favorable entry point and significant upside potential for the company's lead drug candidate.
Dual Upgrades Spark Rally
The rally was triggered by new research coverage from both BofA Securities and Cantor Fitzgerald, according to a report from Investing.com. The timing proved potent, as the initiations followed a week where Apnimed's stock had declined by approximately 19%.
- BofA Securities started coverage with a Buy rating and a $41 price target, based on a discounted cash flow analysis of the company's main drug candidate.
- Cantor Fitzgerald assigned an Overweight rating with a $60 price target, using a similar valuation model that implied roughly double the stock's value at the time of initiation.
Focus on Sleep Apnea Drug Oxnimbi
Both firms' positive outlook is centered on Oxnimbi (AD109), Apnimed's investigational oral therapy for obstructive sleep apnea (OSA). The drug faces a critical regulatory milestone, with the U.S. Food and Drug Administration (FDA) setting a Prescription Drug User Fee Act (PDUFA) goal date of February 28, 2027.
AdIf approved, Oxnimbi would represent a significant development in the OSA market, which is currently dominated by medical devices like CPAP machines and surgical procedures. It would become one of the few pharmacological treatments available, entering a market that also includes therapies like Eli Lilly’s Zepbound.
Market Reaction
Apnimed's stock rose as much as 11.9% on the news, hitting a session high of $29.56 before settling slightly lower. The sharp, company-specific move far outpaced the broader market, which saw modest gains with the S&P 500 up approximately 0.2%.
The combination of fresh institutional attention, a recent pullback in the share price, and a clear upcoming regulatory catalyst created the conditions for Tuesday's strong performance.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.